arrow
N

Nasrollah Ghahramani

penn state health
H指数:25
被引数:2,453

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Prevalence, Mechanisms, and Clinical Significance of Inferior Vena Cava Compression in Autosomal Dominant Polycystic Kidney Disease: A Multicenter Retrospective Cohort Study Based on TriNetX

常染色体显性多囊肾病中下腔静脉受压的患病率、机制及临床意义:一项基于TriNetX的多中心回顾性队列研究

2026-01-220
OAAI
Beyond creatinine: diagnostic accuracy of emerging biomarkers for AKI in the ICU - a systematic review

Matarneh, A.; Akkari, A.; Sardar, S.; Salameh, O.; Dauleh, M.; Matarneh, B.; Abdulbasit, M.; Miller, R.; Verma, N.; Ghahramani, N. 超出肌酐:ICU中AKI新兴生物标志物的诊断准确性——系统综述。Ren. Fail. 2025, 47, 2556295. [Google Scholar] [CrossRef] [PubMed]

2025-12-310
PRE
Cross-sectional and longitudinal associations between fatty liver index and kidney function using updated MASLD and CKD–EPI 2021 definitions: a population-based study with region-specific cutoffs

使用更新的MASLD和CKD–EPI 2021定义,研究脂肪肝指数与肾功能之间的横断面和纵向关联:一项具有地区特异性切点的基于人群的研究

2025-12-150
OAAI
Factors associated with successful transition from continuous renal replacement therapy in critically ill patients: a retrospective cohort study

与危重患者连续肾脏替代治疗成功过渡相关的因素:一项回顾性队列研究

2025-08-070
OA
Outcomes of renal replacement therapy in acute kidney injury: factors associated with dialysis dependence and progression to end-stage renal disease – a MarketScan database analysis

急性肾损伤的肾脏替代治疗效果:与透析依赖及进展至终末期肾病相关的因素——一项基于MarketScan数据库的分析

2025-05-210
OA
Aortic valve calcium as a novel risk marker for kidney function deterioration: The MESA study

主动脉瓣钙化作为肾功能恶化的新型风险标志物:MESA研究

2025-04-210
PRE
Considerations in Controlling for Urine Concentration for Biomarkers of Kidney Disease Progression After Acute Kidney Injury

急性肾损伤后肾脏疾病进展生物标志物尿浓度控制的考虑因素

2022-07-0112
OAAI
Long COVID, a comprehensive systematic scoping review

Long COVID,全面系统的范围界定审查

2021-07-28208
OAAI